[1]Fiorentino F, Asceno R, Rosati N. Does acute myocardial infarction kill more people on weekends? Analysis of inhospital mortality rates for weekend admissions in Portugal[J]. J Health Serv Res Policy, 2018, 23(2):87-97.
[2]Buono A, Pedrotti P, Soriano F, et al. Myocardial infarction with nonobstructive coronary arteries (MINOCA): diagnosis, pathogenesis, therapy and prognosis[J]. G Ital Cardiol (Rome), 2019, 20(9):499-511.
[3]Aydin S, Ugur K, Aydin S, et al. Biomarkers in acute myocardial infarction: current perspectives[J]. Vasc Health Risk Manag, 2019, 15:1-10.
[4]Celebi S, Celebi OO, Cetin S, et al. The usefulness of admission plasma NTpro BNP level to predict left ventricular aneurysm formation after acute STsegment elevation myocardial infarction[J]. Arq Bras Cardiol, 2019, 13(6):1129-1137.
[5]VitkonBarkay I, Lazarovitch T, Marchaim D, et al. Usefulness of serum procalcitonin as a marker for coexisting infection in patients with acute myocardial infarction[J]. Am J Cardiol, 2018, 122(5):729-734.
[6]孙爱国. 急性心肌梗死诊断[J]. 中国医药指南, 2010, 8(13):276-277.
[7]CastroDominguez Y, Dharmarajan K, McNamara RL. Predicting death after acute myocardial infarction[J]. Trends Cardiovasc Med, 2018, 28(2):102-109.
[8]Snorrason EL, Johannnesdottir BK, Aspelund T, et al. Longterm survival of patients with acute myocardial infarction in Iceland[J]. Laeknabladid, 2018, 104(11):491-497.
[9]杨淑娟, 梁锦荣, 李盘石, 等. 血清cTnI, hsCRP, NTproBNP联合检测对急性心肌梗死的诊断价值[J]. 山东医药, 2020, 60(2):75-77.
[10]Reindl M, Tiller C, Holzknecht M, et al. Association of myocardial injury with serum procalcitonin levels in patients with STelevation myocardial infarction[J]. JAMA Netw Open, 2020, 3(6):207-213.
[11]Velazquez EJ, Morrow DA, DeVore AD, et al. Rationale and design of the comparison of Sacubitril/Valsartan versus Enalapril on effect on NTproBNP in patients stabilized from an acute heart failure episode(PIONEERHF) trial[J]. Am Heart J, 2018, 198(7):145-151.
[12]董芳, 任嘉玮, 胡晓娟, 等. 血清NTproBNP及PCT水平对老年心力衰竭合并肺炎患者近期预后的意义[J]. 临床肺科杂志, 2019, 24(3):91-95.
|